FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic

The US Food and Drug Administration (FDA) has granted fast track designation to Life Molecular Imaging’s (LMI) tau positron emission tomography (PET) imaging diagnostic, PI-2620.